<DOC>
	<DOC>NCT00790049</DOC>
	<brief_summary>This is a Phase 1 study, involving both 1-day and 8-day dosing periods, designed to test the safety of investigational study drug ARRY-371797 in healthy subjects. Approximately 48 healthy subjects from the US will be enrolled in this study.</brief_summary>
	<brief_title>A Safety Study of ARRY-371797 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Key Healthy male or female between the ages of 18 and 60 years. Females must be of nonchildbearing potential. Body weight &gt; 50 kg (110 lbs) and &lt; 113 kg (250 lbs). Additional criteria exist. Key A positive test for drugs or alcohol. Use of prescription or nonprescription drugs, herbal or dietary supplements, vitamins, or grapefruit juice within 14 days prior to first dose of study drug. Additional criteria exist.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>